Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
We determined cell viability and cytotoxicity by using tetrazolium reduction assay and Lactate Dehydrogenase (LDH) assay, performed real-time PCR and protein quantification to assess the expression of biomarkers after treating cells with copper peptide (GHK-Cu), copper chloride (CuCl 2 ) and copper acetate (Cu(OAc) 2 )
Two GH secretagogues that both work through the ghrelin receptor (GHSR) will compete for binding sites rather than producing additive effects
PMID 34186147 Mechanisms of subcutaneous absorption of therapeutic proteins
Log each BPC-157 injection (time, dose, site)
US$ 29.28
US$ 23.44
US$ 25.79
US$ 26.49
